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 Abstract 
Background: Serum C reactive protein (CRP) concentrations independently predict the 
development of diabetes, metabolic syndrome and cardiovascular disease. However, the impact 
of dietary factors on serum CRP concentrations in diabetic patients has received limited 
attention. We aimed to investigate the association between dietary factors and serum CRP, 
measured using a high sensitivity (hs-)assay, among diabetic patients with and without 
hypertension and healthy subjects. 
Methods: In this cross-sectional study, diabetics with (n=325) and without hypertension (n=599) 
and healthy individuals (n=1220) were recruited in Mashhad, Iran. Dietary intake was assessed 
by 24-hour recall. Biochemical parameters including serum hs-CRP were measured using 
standard protocols. Stepwise multiple regression analysis was used to predict whether serum hs-
CRP concentration was associated with dietary constituents. 
Results: hs-CRP was significantly higher among hypertensive and non-hypertensive diabetic 
patients compared to healthy subjects (p<0.001). The dietary intake of zinc +6.4% and calcium -
3.4%, and BMI +3.9% explained approximately 13.7% of the variation in serum hs-CRP among 
diabetic hypertensive patients. Approximately, 9.7% of the variation in serum hs-CRP in diabetic 
non-hypertensive patients could be explained by BMI, and intake of sodium, iron and 
cholesterol. In the healthy subjects approximately 4.4% of the total variation in serum hs-CRP 
concentration could be explained by cholesterol consumption and waist circumference. 
Conclusion: Serum hs-CRP concentrations were found to be a significant predictor for 
hypertensive and non-hypertensive diabetic subjects. There was a significant association between 
dietary factors include zinc, iron, sodium and cholesterol and serum hs-CRP whilst there was an 
inverse association between dietary calcium and serum hs-CRP in diabetic hypertensive 
individuals. 
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Introduction 
The prevalence of diabetes mellitus is increasing globally and has become a challenging issue for 
public health in both developed and developing nations.1, 2 In 2015, the number of people with 
diabetes mellitus was estimated to be approximately 415 million by the International Diabetes 
Federation (IDF).3 Approximately 7.7% of Iranian adults (2 million adults) have diabetes 
mellitus.4 
Raised serum inflammatory markers, that include high sensitive C reactive protein (hs-CRP), are 
reported to be associated with several non-communicable conditions including obesity5 
hypertension,6 metabolic syndrome,7 diabetes mellitus and cardiovascular disease.8 hs-CRP is a 
marker of systemic inflammation, and is produced by the liver in response to pro-inflammatory 
cytokines such as interleukin 6 (IL-6).9 
Inflammatory factors are thought to be involved in the pathogenesis of insulin resistance,10 
diabetes mellitus11 and metabolic syndrome,12 and it has been suggested that an elevated hs-CRP 
should be added to the definition of metabolic syndrome.8 Although there is a positive 
association between several factors such as smoking,13 physical inactivity,14 waist 
circumferences,15 BMI15 and serum hs-CRP, the relationship between specific dietary 
components and serum hs-CRP is unclear. A significant inverse association has been shown 
between some dietary items include fruits and vegetables,16 fish and poultry,17 dietary fiber,18 
oleic acid,19 and serum hs-CRP, whereas, a significant positive association has been reported 
between the consumption of red meat,20 trans-fat,21 and saturated fat,22 and serum hs-CRP. Other 
studies have reported no significant association between consumption of fiber,23 carbohydrate, 
protein, total fat,22 and trans fatty acid,24 and serum hs-CRP. In this current study, we aimed to 
investigate the association between the intake of energy and macronutrients including 
carbohydrate, fat and protein, antioxidants including vitamin E and C, and the other specific 
dietary components such as potassium, calcium, magnesium, phosphorus, iron, copper, zinc, 
selenium, iodine, folate and sodium and the level of serum hs-CRP among diabetics with and 
without hypertension and within healthy subjects, derived from a large sample of Iranian adults. 
Methods 
Study design and subject selection 
This cross-sectional study is a part of ongoing large cohort study entitled Mashhad stroke and 
heart atherosclerotic disorder (MASHAD) study.25 As previously described in detail,25 in the first 
phase of the MASHAD study, participants were drawn from three regions in Mashhad using 
stratified cluster randomised sampling. Each region was divided into nine sites centered upon 
Mashhad Healthcare Center divisions. Households with individuals of eligible age between 35 
and 65 years were identified and contacted by telephone to arrange an appointment for the 
formal physical examination.25 Finally, from a total of 2427117 residents of Mashhad city, 11800 
individuals were chosen to participate in the study, of whom a total of 9761 participants, mean 
age 48.1 years old agreed to participate. The demographic, anthropometric and lifestyle data 
were obtained by two expert health care professionals and a nurse. Exclusion criteria were 
pregnancy and lactation, established cardiovascular disease, cancer or chronic kidney and 
consumption of dietary supplements. All diabetic subjects, who were either hypertensive (n=325) 
or non-hypertensive (n=559) were selected for this sub-study. Healthy individuals (subjects 
without any metabolic abnormalities or clinical disorders categorizes as healthy individuals), 
drawn from the same region were matched with the case participants as a healthy group 
(n=1220) (control group).  
Anthropometric and Biochemical Measurements 
Anthropometric measurements, including: weight, height, and waist and hip circumference were 
measured by trained nurses. All of the anthropometric measurements were made in duplicate and 
the average value recorded. Body mass index (BMI) was computed as weight in kilograms 
divided by the square of height in meters. Resting blood pressure was measured three times using 
a standardized protocol and the mean of these records was reported as subject’s blood pressure. 
Fasting blood samples were obtained early in morning after a 12 h fast and stored at -80° C. 
Enzymatic methods (Pars Azmun, Karaj, Iran), were used to measure serum triglycerides, total 
cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol 
(LDL-C), fasting blood glucose and hs-CRP. The levels of biochemical parameters (serum 
triglycerides, total cholesterol, high-density lipoprotein cholesterol [HDL-C], low-density 
lipoprotein cholesterol [LDL-C], fasting blood glucose [FBG] and hs-CRP were determined 
using an autoanalyser (BT3000 biotechnical instruments company, Spain) and commercial kits 
purchased from Pars Azmon. The intra- and inter-assay coefficients of variation of FBG were 
≤1.72% and ≤1.16%, respectively. The intra- and inter-assay coefficients of variation of lipids 
profile were less than 5%. The intra- and inter-assay coefficients of variation of hs-CRP were 
≤2.27% and ≤8.52%, respectively. The standard protocols for the anthropometric and 
biochemical assessment have been reported previously.25 
Assessments of dietary intakes  
Data on the dietary intake of the study participants were collected using 24 hour recall, by a 
trained interviewer. For the analysis of the dietary intake, Dietplan6 software was used (Forest 
field Software Ltd., UK). 
Assessment of metabolic disorders 
Blood pressure equal or greater than 140/90 mmHg was defined as hypertension.26 Individuals 
with a fasting blood glucose ≥ 7 mmol/L) or higher on two separate tests, or those under 
treatment with oral hypoglycemic agents or insulin were considered to be diabetic.27  
Assessment of other variables 
Demographic and lifestyle information including age, smoking status, medical history and drug 
use was obtained by expert interviewers using a structure questionnaire. Physical activity was 
measured using the James and Schofield human energy requirements equations,28 and was 
calculated as the total energy expenditure (TEE):BMR (Basal Metabolic Rate) ratio over a 
twenty-four hour period. Questions on physical activity were based on the James and Schofield 
equations, and were selected from those used in the Scottish Heart Health Study (SHHS)/ 
MONICA questionnaire. Questions were included to assess the time spent on activities during 
work (including housework), outside work, and in bed (resting and sleeping).29 
Statistical methods 
Statistical analysis was undertaken with SPSS software version 16.0 (SPSS® Inc., Chicago, IL). 
Normality of data was assessed by using the Kolomogorov-Smirnov test. We used parametric 
tests for normally distributed data and non-parametric test for non-normally distributed data. 
Between groups comparisons of continuous variables were assessed by analysis of covariance 
(ANCOVA). Chi-square test was used for assessment of categorical data between groups. The 
dietary intakes were found to be non-normally distributed and were therefore compared using 
Mann-Whitney tests. Nutrient intake adjusted for total energy intake through the residual method 
and expressed in grams, milligrams and micrograms. To predict the associations of serum hs-
CRP concentrations and dietary intake, we used linear regression analysis. To enable adjustment 
for potential confounding factors, we entered into the equation the factors age, sex, smoking, 
physical activity, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, 
LDL, HDL, glucose, total cholesterol and triglyceride. A P value of <0.05 was considered 
significant. 
 
Results 
General characteristics and anthropometric measurements in diabetic hypertensive, 
diabetic non-hypertensive patients and healthy subjects 
The general characteristics and anthropometric measurements in diabetic hypertensive and non-
hypertensive patients and healthy subjects are shown in table 1. There were no significant 
differences between smoking status and the percentage of males and females between all three 
groups. However, participants in both diabetic groups were older than the healthy subjects 
(p<0.001). In addition, diabetic hypertensive patients were older than diabetic non-hypertensive 
patients. Body mass index, waist circumference, systolic blood pressure and diastolic blood 
pressure were significantly higher sub-groups of diabetic patients in comparison to the healthy 
subjects. Furthermore, hypertensive diabetic patients had a significant higher body mass index 
and waist circumference, compared with diabetic non-hypertensive subjects. Moreover, patients 
in the diabetic hypertensive group were less active compared to diabetic non-hypertensive 
patients and healthy individuals, Table 1.  
Clinical and biochemical parameters 
Table 2. Shows the clinical and biochemical measurement between patient groups and healthy 
group. Serum hs-CRP, LDL, , total cholesterol, and triglyceride were significantly higher among 
diabetic hypertensive and non-hypertensive patients, in comparison to the healthy subjects. 
Furthermore, total cholesterol, and triglyceride were significantly higher among diabetic 
hypertensive patients compared with non-hypertensive subjects. However, there were no 
significant differences between serum HDL in all three groups (Table 2). 
Dietary intake of macro- and micronutrients in diabetic hypertensive, diabetic non-
hypertensive patients and healthy subjects 
There were no significant differences between the dietary energy, intake of fat and several 
dietary micronutrients including vitamin E, calcium, iron, copper, zinc, selenium, iodine and 
folate in diabetic hypertensive patients and healthy subjects (Table 3). In addition, there were no 
significant differences between dietary energy and dietary micronutrients including vitamins C 
and E, calcium, copper, selenium, iodine and folate in diabetic non-hypertensive patients and 
healthy individuals (Table 3). However, diabetic patients in both sub-groups consumed 
significantly less carbohydrate and more protein, potassium, magnesium, phosphorus and sodium 
than healthy individuals. Moreover, a lower intake of vitamin C was found in the diabetic 
hypertensive patients compared to healthy subjects. Dietary intake of fat, iron and zinc were 
significantly higher among diabetic non-hypertensive patients (Table 3). The differences in 
dietary intake (include energy, macro and micronutrients) of diabetic hypertensive and non-
hypertensive patients were not significant.   
Multivariate analysis 
The dietary intake of zinc (p=0.001, +6.4%) and calcium (p=0.02, -3.4%), and BMI values 
(p=0.01, +3.9%) explained approximately 13.7% of the variation in serum hs-CRP among 
diabetic hypertensive patients using the best fitting models derived from stepwise multiple linear 
regression analysis (Table 4). Approximately, 9.7% of the variation in serum hs-CRP in diabetic 
non-hypertensive patients could be explained by BMI, and intake of sodium, iron and cholesterol 
(Table 5). In the healthy subjects about 4.4% of total variation of hs-CRP concentration could be 
explained by cholesterol consumption and waist circumferences using a similar analysis (Table 
6). 
Discussion 
Results of the current study, showed that serum hs-CRP concentrations in diabetics with and 
without concomitant hypertension, were significantly higher than healthy individuals. In 
addition, some dietary items as well as some anthropometric parameters were significantly 
related to serum hs-CRP concentrations. To the best of our knowledge, this is the first study 
investigating the association between serum high sensitive C reactive protein with dietary intake 
in healthy and diabetic hypertensive and diabetic non-hypertensive patients. It appears that hs-
CRP concentrations and increased in association with both diabetes mellitus8 and hypertension,6 
and hypertension is highly prevalent among diabetic patients,30 we therefore divided the diabetic 
patients into two sub-groups. 
Whilst it has been shown previously that zinc supplementation reduce serum inflammatory 
markers such as hs-CRP and IL-6 among obese young women31in our study zinc was positively 
associated with hs-CRP in the diabetic hypertensive patients suggesting more studies particularly 
longitudinal studies might be needed to clarify this relationship. 
We found, a significant association between the intake of iron and hs-CRP among diabetic non-
hypertensive patients. It has been shown previously that a high consumption of iron is associated 
with increased risk of coronary heart disease and type 2 diabetes.32, 33 Indeed, has been 
previously suggested that iron could cause an increased production of reactive oxygen species, 
oxidative stress, and inflammation.34 Results of a recent meta-analysis has shown that the intake 
of heme iron is positively associated with coronary heart diseases (CHD),35 possibly related to 
the potential tissue-damaging inflammation which may be caused by heme iron in the oxidation 
of LDL.35-37  
We found that, serum hs-CRP concentrations in both diabetic sub-groups patients, was 
approximately two-fold higher than for healthy individuals. In addition, BMI was significantly 
associated with elevated serum hs-CRP in both diabetic groups. Earlier reports have indicated 
that obesity, BMI, insulin resistance and metabolic syndrome are positively associated with low-
grade inflammation particularly elevated blood hs-CRP.12, 15, 38-41 It has been suggested that an 
increased production of inflammatory markers such as IL-6 and tumor necrosis factor-alpha 
(TNF-α) associated with obesity, result in an increased synthesis and secretion of hs-CRP by the 
liver, and this may also lead to insulin resistance and diabetes mellitus among obese 
individuals.40, 42 Following a healthy lifestyle, including a healthy diet and increased physical 
activity, both of which can normalize weight, might be helpful to protect against elevated hs-
CRP and several chronic diseases related to it.  
We found an inverse association between dietary calcium and serum hs-CRP among diabetic 
hypertensive. There are limited data on the relationship between dietary calcium and serum hs-
CRP concentrations. However, in a previous study examining the association between dairy 
products (highly source of calcium) intake and inflammatory markers such as hs-CRP and IL-6 
and TNF-α, a significant reverse association was found between consumption of servings of 
dairy products per week and inflammatory markers.43 In addition, in a study of Iranian women, a 
significant inverse association was found between the intake of low-fat dairy and hs-CRP though 
the relationship between intake of total dairy products and hs-CRP was not significant.44 With 
regard to the inverse association between calcium intake and insulin resistance, obesity and CHD 
risk,45-48 and the positive association between BMI and serum hs-CRP level,15, 38 it is possible 
that our results on calcium intake and hs-CRP might be explained through an impact of dietary 
calcium on body weight.  
Dietary intake of sodium was also associated with hs-CRP among diabetic non-hypertensive 
patients. A direct role of sodium in stimulation of inflammatory response and hypothesis that 
proposed sodium may increase gene expression of inflammatory factors might be the possible 
mechanisms to explain the role of sodium in increasing inflammatory response.49, 50 An 
association between sodium intake and serum CRP, which may influenced by BMI was found in 
a previous observational study,51 which is consistent with our results. In their study, Zhu et.al 
found a significant direct association between higher sodium intake and adipocyte dysfunction 
and inflammation among adolescents.52 However, in a recent randomized controlled clinical trial, 
investigating the effect of Dietary Approaches to Stop Hypertension (DASH diet), which 
contained restricted amount of sodium, on inflammation in gestational diabetes, there was no 
significant difference between serum hs-CRP among intervened and control groups.53 
We also found a significant positive association between cholesterol intake and hs-CRP 
concentration in the diabetic, non-hypertensive and healthy individuals. Hypercholesterolemia 
and atherosclerosis are related to the consumption of high-fat, high-cholesterol diets, causing an 
accumulation of cholesterol in immune cells such as macrophages, which increases inflammatory 
response.54 Furthermore, results of a previous rodent study indicated that hepatic inflammation 
occurs by dietary cholesterol, rather than liver steatosis suggesting dietary cholesterol should be 
considered as a salient factor of hepatic inflammation.55 
With respect to the significant positive association between waist circumferences and plasma hs-
CRP in healthy participants in this study, previous studies have investigated the relationship 
between component of metabolic syndrome and serum hs-CRP, and it has been shown that 
central obesity is a major determinant of increased hs-CRP in metabolic syndrome.56 Similarly, 
other reports have indicated that waist circumference is an important determinent of serum hs-
CRP.15, 57 In a study conducted among healthy men, there was a significant association between 
abdominal adipose tissue and elevated hs-CRP, suggesting that although the best predictor of 
CRP levels is the amount of total body fat, abdominal fat deposition should be considered as a 
major determinant of an inflammatory metabolic state.58 
This present study has some limitations. The cross-sectional study design cannot be used to 
impute causality. Furthermore we obtained dietary intake of the study participants using self-
report questionnaire, which indicated measurement bias. Finally, we used 24-hours food recall to 
collect dietary intake. Although this method has been widely applied, it depends on memory and 
under- or over-reporting might lead to imprecision.  
In conclusion, our findings highlight the significant association between serum hs-CRP 
concentration in diabetics with and without hypertension, and demonstrate that BMI and some 
dietary constituents including zinc, iron, sodium and cholesterol have a significant association 
with serum hs-CRP. Dietary calcium might have a protective effect against elevated hs-CRP in 
diabetic patients. More longitudinal study, particularly randomized clinical trial using more 
population will be required to clarify the exact association between serum high sensitive C 
reactive protein and dietary intake in diabetic patients.  
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Table 1 
General characteristics and anthropometric measurements in patient and control subjects* 
Group Diabetic hypertensive 
(n=325) 
Diabetic non-hypertensive 
(n=559) 
 
Control 
(n=1220) 
P1 
 
 
P2 P3 
Age (y) 54±6.9# 50.8±7.4 46.5±7.9 <0.001 <0.001 <0.001 
Males/females 131/194 210/349 495/725 0.94 0.23 0.33 
Current smoking [n (%)] 15.7 22 19.5 0.12 0.22 0.05 
Physical activity level (PAL) 1.52±0.3 1.58±0.27 1.58±0.26 0.001 0.97 0.002 
BMI (Kg/m2) 29.8±4.6 28.3±4.6 27.2±4.5 <0.001 <0.001 <0.001 
Waist circumference 101.6±11.1 97.8±11.7 93.5±11.5 <0.001 <0.001 <0.001 
Systolic blood pressure 148±16 118.4±11.3 114.4±11.7 <0.001 <0.001 <0.001 
Diastolic blood pressure 91.6±8.4 75.9±7.5 74.7±8.2 <0.001 0.005 <0.001 
* Continuous variables were compared by chi-square test and categorical variables were compared by ANCOVA 
#Mean ± standard deviation 
1 Diabetic hypertensive in compared to the control 
2 Diabetic non-hypertensive in compared to the control 
3 Diabetic hypertensive in compared to the Diabetic non-hypertensive 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 
Serum biochemical measurements in patient and control subjects * 
Group 
Variable 
Diabetic hypertensive 
 
Diabetic non-hypertensive Control P2 P3 P4 
hs-CRP 2.9 (4.3) # 2.5 (4.06) 1.3 (1.75) <0.001 <0.001 0.16 
LDL 125.5±43.2ǂ 121±39.7 116.3±32 <0.001 0.01 0.3 
HDL 42.3±9.6 41.7±10.1 42.3±9.6 0.93 0.23 0.62 
Glucose 195.1±59.6 196±61.1 78.6±9.9 <0.001 <0.001 0.77 
Total cholesterol 213.3±49 202.4±46.1 186.8±35.2 <0.001 <0.001 0.005 
Triglyceride 172 (120) 153 (123) 112 (80) <0.001 <0.001 0.002 
* Continuous variables were compared by chi-square test and categorical variables were compared by ANCOVA or Mann-Whitney 
# Median (Interquartile range) 
ǂ Mean ± standard deviation 
2Diabetic hypertensive in compared to the control 
3 Diabetic non-hypertensive in compared to the control 
4 Diabetic hypertensive in compared to the Diabetic non-hypertensive 
  
 
 
 
 
 
 
 
 
Table 3 
Comparison of macro- and micronutrient dietary intakes between patients and control subjects * 
Groups 
 
Dietary intakes 
Diabetic hypertensive 
subjects 
 
Diabetic non-hypertensive 
subjects 
 
Healthy subjects P1 
 
 
P2 P3 
Macronutrients 
 Energy (Kcal) 1966 (1555-2447)# 1867 (1422-2310) 1820 (1443-2197) 0.14 0.54 0.42 
 Carbohydrate (g) 240.7 (201.7-279.7) 229.1 (196.9-261.2) 243.2 (212.6-273.8) 0.01 <0.001 0.33 
 Fat (g) 69 (55-83) 72.4 (58.7-86) 69.3 (257.3-281.3) 0.12 0.01 0.74 
 Protein (g) 69.3 (58.1-80.4) 72.4 (61.6-83.2) 68.3 (59-77.6) 0.04 <0.001 0.9 
Antioxidants 
 Vitamin E (mg) 16.3 (9.2-23.3) 17.1 (9.9-24.3) 16.5 (10.8-22.2) 0.8 0.57 0.8 
 Vitamin C (mg) 61.6 (14.3-108.9) 78.6 (25.7-131.4) 77.5 (28.2-126.7) 0.03 0.56 0.4 
Others 
 Potassium (mg) 2915 (2303-3527) 2898 (2238-3558) 2766 (2282-3250) 0.01 0.005 0.7 
 Calcium (mg) 859 (564-1154) 839 (576-1102) 841 (632-1049) 0.2 0.92 0.23 
 Magnesium (mg) 252.5 (190.1-314.7) 253.7 (210.5-296.8) 230.6 (150.6-310.6) 0.003 <0.001 0.78 
 Phosphorus (mg) 1377 (1120-1634) 1343 (1105-1581) 1286 (1101.3-1470.7) 0.001 0.005 0.24 
 Iron (mg) 9.5 (6-13) 10.8 (7.5-14) 9.5 (6.7-12.3) 0.2 <0.001 0.76 
 Cooper (mg) 1.8 (1.47-2.13) 1.8 (1.53-2.07) 1.7 (1.47-1.93) 0.34 0.3 0.41 
 Zinc (mg) 9.1 (7.1-11.1) 9.5 (7.5-11.5) 9 (7.4-10.6) 0.22 0.004 0.7 
 Selenium (mg) 29.4 (15.9-42.9) 31.3 (17.6-44.9) 34.2 (22.7-45.7) 0.07 0.4 0.65 
 Iodine (mcg) 91.2 (32.4-149.9) 97.4 (35.5-159.2) 108.3 (50.3-166.3) 0.35 0.14 0.21 
 Folate (mcg) 220.9 (144-297.7) 229.5 (166.3-292.6) 217.9 (159.8-276) 0.5 0.4 0.24 
 Sodium (mg) 2435 (1453-3416) 2425 (1510-3339) 1908 (1105-2710) <0.001 <0.001 0.41 
*Obtained using Mann-Whitney test 
#Median (Interquartile range) 
1 Diabetic hypertensive in compared to the control 
2 Diabetic non-hypertensive in compared to the control 
3 Diabetic hypertensive in compared to the Diabetic non-hypertensive 
  
Table 4 
Multifactorial analysis of serum C-Reactive Protein * (Diabetic hypertensive) 
Group and confounders  β R2 P 
           % 
Zinc 0.914 6.4 0.001 
BMI 0.526 3.9 0.01 
Calcium -0.005 3.4 0.02 
Sodium 0.001 0.02 0.33 
Iron 0.07 0.006 0.29 
Cholesterol 0.006 0.01 0.13 
Waist circumference 0.05 0.003 0.38 
* Obtained from linear regression. 
 
Table 5 
Multifactorial analysis of C-Reactive Protein * (Diabetic non-hypertensive) 
Group and confounders  β R2 P 
% 
BMI 0.324 3.1 0.009 
Sodium 0.001 2.9 0.005 
Iron 0.226 2.1 0.025 
Cholesterol 0.025 1.6 0.047 
Waist circumference 0.06 0.006 0.19 
Zinc 0.004 0.12 0.28 
Calcium -0.001 0.001 0.57 
* Obtained from linear regression. 
 
Table 6 
Multifactorial analysis of C-Reactive Protein * (control group) 
Group and confounders  β R2 P 
% 
Cholesterol 0.007 2.2 0.002 
Waist circumference 0.104 2.2 0.002 
BMI -0.05 0.000 0.49 
Sodium 0.001 0.000 0.88 
Iron 0.04 0.001 0.36 
Zinc -0.01 0.000 0.81 
Calcium 0.000 0.000 0.61 
* Obtained from linear regression. 
  
